Pfizer Ltd (PFIZER)

Pfizer Ltd (PFIZER) is listed on the NSE in the Pharmaceuticals sector, Pharmaceuticals & Biotechnology industry. Market capitalisation: 21595.44 Cr. Figures below are as reported and are shown with their source and date.

Educational use only — GoQuant is a research tool. This page lists company facts only and is not a recommendation. Investment advice is provided by FINOME TECHNOLOGIES PVT LTD (AltQube), SEBI-registered Investment Adviser, registration no. INA000018373, under a signed advisory agreement and after a risk profile. Past performance is not indicative of future results.

Company profile

Sector
Pharmaceuticals
Industry
Pharmaceuticals & Biotechnology
Market cap (₹ Cr)
21,595.44

Pfizer Ltd. engages in the business of manufacturing, marketing, trading, import and export of pharmaceutical products. The company is headquartered in Mumbai, Maharashtra and currently employs 1,702 full-time employees. The firm is engaged in manufacturing, marketing, trading and export of pharmaceutical products. The firm has its own manufacturing facility at Goa. The firm has various independent contract/third party manufacturers based across India. Its product portfolio includes vaccine, anti-infectives, cardiac, pain, maternal nutrition, gastrointestinal, contraceptives, anti-inflammatory, nutrition and immunity, and respiratory. The firm's vaccine business is focused on Prevenar 13, a pneumococcal conjugate vaccine that is administered to infants who are six weeks and older as part of primary vaccination, toddlers, adolescents, adults, and elderly population. Its inflammation and immunology portfolio includes two advanced therapies, which cater to patients suffering from diseases related to chronic immune system such as rheumatoid arthritis, ankylosing spondylitis, juvenile idiopathic arthritis, psoriasis and ulcerative colitis.

Source: finedge · as of 2026-09-29

Price, last year

Last close (₹): 3,688.9

Source: quantro_screener_metrics_job · as of 2026-10-22

Key figures

P/E
23.36
52-week high
5,446
52-week low
3,675
Revenue CAGR, 3 years (%)
1.29
Revenue CAGR, 5 years (%)
2.39
EPS CAGR, 3 years (%)
5.01
EPS CAGR, 5 years (%)
7.74

Source: quantro_screener_metrics_job · as of 2026-10-23

Annual summary

Year endedRevenue (₹ Cr)PAT (₹ Cr)EPS (₹)
Mar 20262,519.65722.43157.92
Mar 20252,281.35767.6167.79
Mar 20242,193.17551.33120.52
Mar 20232,424.76623.93136.38
Mar 20222,610.99612.56133.9

Source: finedge · as of 2026-07-21

Shareholding and promoter pledge

Promoter
63.92%
FII
2.81%
DII
16.89%
Public
16.37%
Promoter shares pledged
0%

Source: finedge · as of 2026-03-31

Similar companies

Source: quantro_company_profiles · as of 2026-10-23

Frequently asked questions

What does Pfizer Ltd do?
Pfizer Ltd. engages in the business of manufacturing, marketing, trading, import and export of pharmaceutical products. The company is headquartered in Mumbai, Maharashtra and currently employs 1,702 full-time employees. The firm is engaged in manufacturing, marketing, trading and export of pharmaceutical products. The firm has its own manufacturing facility at Goa. The firm has various independent contract/third party manufacturers based across India. Its product portfolio includes vaccine, anti-infectives, cardiac, pain, maternal nutrition, gastrointestinal, contraceptives, anti-inflammatory, nutrition and immunity, and respiratory. The firm's vaccine business is focused on Prevenar 13, a pneumococcal conjugate vaccine that is administered to infants who are six weeks and older as part of primary vaccination, toddlers, adolescents, adults, and elderly population. Its inflammation and immunology portfolio includes two advanced therapies, which cater to patients suffering from diseases related to chronic immune system such as rheumatoid arthritis, ankylosing spondylitis, juvenile idiopathic arthritis, psoriasis and ulcerative colitis.
Which sector is Pfizer Ltd in?
Pfizer Ltd is in the Pharmaceuticals sector, Pharmaceuticals & Biotechnology industry.
What are Pfizer Ltd's latest annual revenue and profit?
For the year ended Mar 2026: revenue 2519.65 Cr, profit after tax 722.43 Cr.
What is the promoter holding and pledge in Pfizer Ltd?
Promoter holding is 63.92%; pledged shares are 0.00% of the promoter holding.
Which companies are similar to Pfizer Ltd?
Companies in the same sector of similar size: Granules India Ltd, Eris Lifesciences Ltd, Onesource Specialty Pharma Ltd, Caplin Point Laboratories Ltd, Piramal Pharma Ltd, Cohance Lifesciences Ltd.
Want more history and detail? Create a free account for the full price history, quarterly statements, balance sheet and cash flow.

Figures computed 2026-10-23.